Therapiealternativen zur chirurgischen Versorgung maligner Lidtumoren und deren Vorläuferstufen
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://link.springer.com/content/pdf/10.1007/s00347-020-01072-y.pdf
Reference28 articles.
1. Anders M, Sporl E, Krantz H, Matthaus W, Seiler T (1995) Cryotherapy of malignant eyelid tumors. Ophthalmologe 92(6):787–792
2. Avril M, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, Guillaume J, Chalon R, Petit J, Sancho-Garnier H, Prade M, Bouzy J, Chassagne D (1997) Basal cell carcinoma of the face: surgery or radiotherapy? results of a randomized study. Br J Cancer 76(1):100–106. https://doi.org/10.1038/bjc.1997.343
3. Buschmann W (2002) A reappraisal of cryosurgery for eyelid basal cell carcinomas. Br J Ophthalmol 86(4):453–457
4. Cannon PS, O’Donnell B, Huilgol SC, Selva D (2011) The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions. Br J Ophthalmol 95(12):1682–1685. https://doi.org/10.1136/bjo.2009.178202
5. Cox KF, Margo CE (2016) Role of vismodegib in the management of advanced periocular basal cell carcinoma. Cancer Control 23(2):133–139. https://doi.org/10.1177/107327481602300207
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Medikamentöse Therapie von malignen Lidtumoren;Klinische Monatsblätter für Augenheilkunde;2024-02-27
2. Plasma Exeresis for the Treatment of Benign Eyelid Lesions: A New Surgical Approach;Ophthalmic Plastic & Reconstructive Surgery;2024-02-27
3. Medikamentöse Therapie von malignen Lidtumoren;Augenheilkunde up2date;2024-02
4. Long-term efficacy and safety of imiquimod 5% and fluorouracil 1% creams in medical monotherapy of complex eyelid basal cell carcinomas;European Journal of Ophthalmology;2021-07-28
5. Advances in the management of eyelid tumors;IP International Journal of Ocular Oncology and Oculoplasty;2021-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3